Vaxcyte Financial Statements
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
65.02-1.94 (-2.90%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 65.02 0.00%
Vaxcyte revenue and earnings
Vaxcyte reported a net loss of $766.6 million, compared with a loss of $463.9 million a year earlier. Diluted earnings per share came in at -$5.63.
Summary generated from market data by MetaCap's automated system. Methodology
Vaxcyte income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 923.67M | 569.55M | 468.04M | 232.26M | 103.67M | 89.58M | 54.15M | 35.53M |
| Research & Development | 794.31M | 476.64M | 332.34M | 169.45M | 78.41M | 73.56M | 45.61M | 30.14M |
| Operating Income | -923.67M | -569.55M | -468.04M | -232.26M | -103.67M | -89.58M | -54.15M | -35.53M |
| Interest Expense | — | 0 | 0 | 2.00K | 7.00K | 7.00K | 40.00K | 75.00K |
| Other Income (Expense) | 157.05M | 105.62M | 65.78M | 8.77M | 3.59M | 364.00K | 3.88M | 6.05M |
| Income Tax | 0 | 0 | 0 | — | — | — | — | — |
| Net Income | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M | -89.22M | -50.27M | -29.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| EPS (Basic) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -3.02 | -13.25 | -8.12 |
| EPS (Diluted) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -3.02 | -13.25 | -8.12 |
| Shares Outstanding (Basic) | 136.09M | 122.00M | 97.16M | 64.88M | 51.92M | 29.55M | 3.80M | 3.63M |
| Shares Outstanding (Diluted) | 136.09M | 122.00M | 97.16M | 64.88M | 51.92M | 29.55M | 3.80M | 3.63M |
| EBITDA | -907.28M | -562.54M | -464.88M | -229.42M | -101.87M | -88.18M | -52.92M | -34.50M |
This table shows 8 annual periods of Vaxcyte's income statement, from FY 2025 back to FY 2018, across 12 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow PCVX's reporting calendar. What is a income statement?